Cargando…

Characterization and Pharmacokinetic Study of Aprepitant Solid Dispersions with Soluplus(®)

Solid dispersions are a useful approach to improve the dissolution rate and bioavailability of poorly water-soluble active pharmaceutical ingredients (APIs). The aim of this study was to improve the physicochemical properties and bioavailability of a poorly water-soluble aprepitant by preparation of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Jinwen, Zou, Meijuan, Piao, Hongyu, Liu, Yi, Tang, Bo, Gao, Ying, Ma, Ning, Cheng, Gang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6272549/ https://www.ncbi.nlm.nih.gov/pubmed/26102068 http://dx.doi.org/10.3390/molecules200611345

Ejemplares similares

Preparation and Characterization of Aprepitant Solid Dispersion with HPMCAS-LF
por: Liu, Jinwen, et al.
Publicado: (2022)

Soluplus-Mediated Diosgenin Amorphous Solid Dispersion with High Solubility and High Stability: Development, Characterization and Oral Bioavailability
por: Liu, Pei, et al.
Publicado: (2020)

Stabilizing Effect of Soluplus on Erlotinib Metastable Crystal Form in Microparticles and Amorphous Solid Dispersions
por: Jia, Shuyu, et al.
Publicado: (2022)

Design and Characterization of Phosphatidylcholine-Based Solid Dispersions of Aprepitant for Enhanced Solubility and Dissolution
por: Yeo, Sooho, et al.
Publicado: (2020)

Preparation and Characterization of Celecoxib Dispersions in Soluplus(®): Comparison of Spray Drying and Conventional Methods
por: Homayouni, Alireza, et al.
Publicado: (2015)

Soluplus(®)/TPGS-based solid dispersions prepared by hot-melt extrusion equipped with twin-screw systems for enhancing oral bioavailability of valsartan
por: Lee, Jae-Young, et al.
Publicado: (2015)

Enhancement of the Bioavailability and Anti-Inflammatory Activity of Glycyrrhetinic Acid via Novel Soluplus(®)—A Glycyrrhetinic Acid Solid Dispersion
por: Wang, Hao, et al.
Publicado: (2022)

The Self-Assembly Soluplus Nanomicelles of Nobiletin in Aqueous Medium Based on Solid Dispersion and Their Increased Hepatoprotective Effect on APAP-Induced Acute Liver Injury
por: Ning, Jinrong, et al.
Publicado: (2023)

Physicochemical, Pharmacokinetic, and Toxicity Evaluation of Soluplus(®) Polymeric Micelles Encapsulating Fenbendazole
por: Jin, Ik Sup, et al.
Publicado: (2020)

Artemether-Soluplus Hot-Melt Extrudate Solid Dispersion Systems for Solubility and Dissolution Rate Enhancement with Amorphous State Characteristics
por: Fule, Ritesh A., et al.
Publicado: (2013)

Comparison of Pharmacokinetics of Aprepitant in Healthy Chinese and Caucasian Subjects
por: Yang, Meng-Jie, et al.
Publicado: (2020)

Spray-Dried Amorphous Solid Dispersions of Griseofulvin in HPC/Soluplus/SDS: Elucidating the Multifaceted Impact of SDS as a Minor Component
por: Rahman, Mahbubur, et al.
Publicado: (2020)

Data regarding particle size distribution, thermal properties and gaseous phase hydration of co-milled solid dispersions composed of tadalafil and Soluplus
por: Kubat, Karol, et al.
Publicado: (2022)

Comparison of two self-assembled macromolecular prodrug micelles with different conjugate positions of SN38 for enhancing antitumor activity
por: Liu, Yi, et al.
Publicado: (2015)

Influence of aprepitant on the pharmacodynamics and pharmacokinetics of gliclazide in rats and rabbits
por: Kura, Raghunandan Reddy, et al.
Publicado: (2018)

Self-Assembly of Soluplus in Aqueous Solutions: Characterization and Prospectives on Perfume Encapsulation
por: Sofroniou, Constantina, et al.
Publicado: (2022)

Angelica gigas Nakai and Soluplus-Based Solid Formulations Prepared by Hot-Melting Extrusion: Oral Absorption Enhancing and Memory Ameliorating Effects
por: Piao, Jingpei, et al.
Publicado: (2015)

Preparation of Solid Dispersions of Simvastatin and Soluplus Using a Single-Step Organic Solvent-Free Supercritical Fluid Process for the Drug Solubility and Dissolution Rate Enhancement
por: Nandi, Uttom, et al.
Publicado: (2021)

Effects of Aprepitant on the Pharmacokinetics of Controlled-Release Oral Oxycodone in Cancer Patients
por: Fujiwara, Yutaka, et al.
Publicado: (2014)

Formulation Characterization and Pharmacokinetic Evaluation of Amorphous Solid Dispersions of Dasatinib
por: Dharani, Sathish, et al.
Publicado: (2022)

Preparation of Evodiamine Solid Dispersions and Its Pharmacokinetics
por: Xu, H., et al.
Publicado: (2011)

Investigation of the in vitro performance difference of drug-Soluplus® and drug-PEG 6000 dispersions when prepared using spray drying or lyophilization
por: Altamimi, Mohammad A., et al.
Publicado: (2017)

Application of Soluplus to Improve the Flowability and Dissolution of Baicalein Phospholipid Complex
por: Fan, Junting, et al.
Publicado: (2017)

Amorphicity and Aerosolization of Soluplus-Based Inhalable Spray Dried Powders
por: Adhikari, Bishal Raj, et al.
Publicado: (2022)

Preparation and Characterization of Nanosuspension of Aprepitant by H96 Process
por: Kalvakuntla, Sunethra, et al.
Publicado: (2016)

Preparation and pharmacokinetics in vivo of linarin solid dispersion and liposome
por: Huang, Yingying, et al.
Publicado: (2022)

Enhancing oral bioavailability of quercetin using novel soluplus polymeric micelles
por: Dian, Linghui, et al.
Publicado: (2014)

Soluplus(®) polymeric nanomicelles improve solubility of BCS-class II drugs
por: Pignatello, Rosario, et al.
Publicado: (2022)

Fabrication and Characterization of Paclitaxel and Resveratrol Loaded Soluplus Polymeric Nanoparticles for Improved BBB Penetration for Glioma Management
por: Hussain, Talib, et al.
Publicado: (2021)

Enhanced oral bioavailability of magnolol via mixed micelles and nanosuspensions based on Soluplus(®)-Poloxamer 188
por: Li, Guoyuan, et al.
Publicado: (2020)

Supersaturated polymeric micelles for oral silybin delivery: the role of the Soluplus–PVPVA complex
por: Zhu, Chunliu, et al.
Publicado: (2019)

The interaction of ifosfamide and aprepitant in gynecologic malignancies()
por: Shindorf, Mackenzie L., et al.
Publicado: (2013)

Aprepitant for the Treatment of Chronic Refractory Pruritus
por: He, Alice, et al.
Publicado: (2017)

A Novel Semi-Solid Self-Emulsifying Formulation of Aprepitant for Oral Delivery: An In Vitro Evaluation
por: Nazlı, Hakan, et al.
Publicado: (2023)

Characterization of Olanzapine-Solid Dispersions
por: Krishnamoorthy, Venkateskumar, et al.
Publicado: (2011)

Clinical Observation of Gene Polymorphism of Olanzapine or Aprepitant in Prevention of CINV
por: Jin, Yilan, et al.
Publicado: (2021)

Treatment for Refractory Pruritus Using Oral Aprepitant
por: Huh, Joon Won, et al.
Publicado: (2016)

Aprepitant for the management of nausea with inpatient IV dihydroergotamine
por: Chou, Denise E., et al.
Publicado: (2016)

Emerging Role of Aprepitant in Cannabis Hyperemesis Syndrome
por: Parvataneni, Swetha, et al.
Publicado: (2019)

Micellisation Mechanism and Behaviour of Soluplus(((®)))–Furosemide Micelles: Preformulation Studies of an Oral Nanocarrier-Based System
por: Alopaeus, Julia F., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hge43ijn5cfptgt6ro24oqgkec